Hyper-late Major Response after 5 Years of Nivolumab: Role of Treatment Beyond Progression in Head and Neck Cancer.
Anti-Cancer Drugs（2024）
关键词
anti-PD1,head and neck cancer,immunotherapy,nivolumab,treatment beyond progression
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要